Helen Boucher, M.D.
Contributor
- Chief, Division of Geographic Medicine and Infectious Diseases
- Director, Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR)
- Director, Heart Transplant and Ventricular Assist Device Infectious Diseases Program
Areas of Special Interest
- Infections in immunocompromised patients
- S. aureus infections
- Development of new anti-infective agents
Professional Recognition & Appointments
- Treasurer, Infectious Diseases Society of America
- Voting Member, Presidential Advisory Council on Combatting Antibiotic-Resistant Bacteria
- Board of Trustees of the Physicians of Tufts Medical Center and The College of the Holy Cross
- IDSA Society Citation Award (2015)
- Associate Editor, Antimicrobial Agents and Chemotherapy
Publication Highlights
Numerous peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts including:
- Antibiotic Development Incentives that Reflect Societal Value of Antibiotics. Clin Infect Dis - 2020
- Emergency Use Authorication of Remdesivir: The Need for a Transparent Distribution Process. JAMA - 2020
- Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. Open Forum Infect Dis - 2020
- The Infectious Diseases Society of America's 10 x '20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 x '20 a Possibility? Clin Infect Dis - 2019
- Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time? N Engl J Med - 2019
- Sequential, Multiple-Assignment, Randomized Trials for Comparing Personalize Antibiotic Strategies (SMART-COMPASS). Clin Infect Dis -2019
- Drug-Use and Post-Operative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-Analysis. Clin Infect Dis - 2019
- A Multicenter, Randomized, Doubleblind Trial Comparing Efficacy and Safety of Imipenem/ Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. Clin Infect Dis - 2019
Education
- College of the Holy Cross (B.A.)
- University of Texas Medical School at Houston (M.D.)
- Deaconess Hospital (Residency, Chief Resident)
- Beth Israel Deaconess Medical Center (Fellowship)
Disclosures
- Nothing to disclose